Menassie Taddese
Fortune : 148 412 $ au 30/09/2026
Fortune : 148 412 $ au 30/09/2026
Mr. Menassie Taddese is an Independent Director at Medexus Pharmaceuticals, Inc. He is on the Board of Directors at Xeris Biopharma Holdings, Inc. and Medexus Pharmaceuticals, Inc. Mr. Taddese was previously employed as a President-Emerging Markets by Viatris, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/09/2025 | 42 869 ( 0,14 % ) | 148 412 $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 06/02/2023 |
| XERIS BIOPHARMA HOLDINGS, INC. | Directeur/Membre du Conseil | 02/11/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| VIATRIS INC. | Corporate Officer/Principal | 01/12/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medexus Pharmaceuticals, Inc.
Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Viatris, Inc.
Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national